Essais liés9clinical trials
VilleLondonlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06152575

Ouvrir le site du centre

Essais cliniques associés

9
MoléculeIndication / populationPhaseNCTTitreStatut
Vagus Nerve Stimulation (VNS) Therapy SEP Phase 4 NCT01118455 Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures TERMINATED
Elranatamab Cancer Phase 3 NCT06152575 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) RECRUITING
ION363 Sclérose latérale amyotrophique Phase 3 NCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) ACTIVE_NOT_RECRUITING
Pridopidine Sclérose latérale amyotrophique Phase 3 NCT07322003 PREVAiLS — Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS RECRUITING
Standard lymphodepletion regimen Myasthénie Phase 2/3 NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis RECRUITING
CC-97540 Lupus Phase 2 NCT07015983 A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) ACTIVE_NOT_RECRUITING
Corabotase Migraine Phase 2 NCT06625060 MERANTI — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults ACTIVE_NOT_RECRUITING
BHV-7000 Épilepsie Phase 2/3 NCT06309966 RISE 3 — Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy ACTIVE_NOT_RECRUITING
Relief — Peripheral Nerve Stimulation Registry for Intractable Migraine Headache Migraine À vérifier NCT02227758 Relief — Peripheral Nerve Stimulation Registry for Intractable Migraine Headache COMPLETED